Regulation
FDA Clears First Neurostimulation Device for PTSD
Neurovalens received FDA clearance for Modius Spero, the first neurostimulation device approved for post-traumatic stress disorder treatment. The device will become available to veterans through the VA system beginning summer 2026.
The source
This brief is a MedIndexer summary of reporting by MedCity News. To read the full story, head to the source.
Read the full story at MedCity News